Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 7/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12424270 | 0.87 | HDAC8 (0.55) | HDAC8ALDH1A1GAATSHRCYP3A4 | |
| SCHEMBL12424516 | 0.85 | HDAC8 (0.53) | HDAC8ALDH1A1GAATSHRCYP3A4 | |
| SCHEMBL25676008 | 0.78 | GRIN2B (0.56) | ALDH1A1GAATSHRCYP3A4CYP17A1 | |
| SCHEMBL12193354 | 0.76 | HDAC8 (0.52) | HDAC8ALDH1A1GAAMEN1LMNA | |
| SCHEMBL12217715 | 0.76 | HDAC8 (0.52) | HDAC8ALDH1A1CYP3A4MEN1LMNA | |
| SCHEMBL904569 | 0.76 | DPP4 (0.50) | HDAC8ALDH1A1GAATSHRDPP4 | |
| SCHEMBL12424432 | 0.75 | ALDH1A1 (0.64) | ALDH1A1TSHRMEN1LMNAMAPT | |
| SCHEMBL836643 | 0.74 | KMT2A (0.58) | HDAC8ALDH1A1CYP3A4MEN1LMNA | |
| SCHEMBL7340811 | 0.74 | CNR1 (0.52) | HDAC8ALDH1A1GAACYP3A4MEN1 | |
| SCHEMBL7327467 | 0.74 | CNR1 (0.55) | HDAC8ALDH1A1CYP3A4MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201593-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201593-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | CCNY, CCNA1, CCNA2 | HDAC8 775/4885ALDH1A1 1168/4885GAA 2545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.